Adamis Pharmaceuticals reported 27.79M in Current Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Adamis Pharmaceuticals ADMP:US 27.79M 7.41M
Adma Biologics ADMA:US $ 239.8M 31.07M
Brainstorm Cell Therapeutics BCLI:US $ 19.26M 4.02M
Cara Therapeutics CARA:US $ 151.76M 21.53M
Cerulean Pharma CERU:US $ 47.82M 7.48M
Glaxosmithkline GSK:US $ 28988M 10314M
GlaxoSmithKline GSK:LN 28.99B 10.31B
Merk MRK:US $ 31184M 918M
Pfizer PFE:US $ 54420M 5273M